Tratamiento de la cirrosis biliar primaria con ácido ursodesoxicólico. Resultados a corto y medio plazo y relación con el estudio de la enfermedad

We present the results of the treatment with ursodeoxycholic acid (UDCA, 7-9 mg/kg body weight daily) of 17 patients with primary biliary cirrhosis (8 in stages I-II; 9 in stages III-IV). At two months the mean values of alkaline phosphatase, gammaglutamiltranspeptidase, alanine and aspartate aminot...

Descripción completa

Detalles Bibliográficos
Autores: Garcia-Villarreal, L. (Luis)|||/items/397c8983-3fdb-45d3-9d5b-20b34f79cc6a, Zozaya, J.M. (José Manuel)|||/items/70a8a1ed-51c0-4166-9547-ecde1a29e8a1, Garcia, N. (Nicolás)|||/items/f28987d6-9dc4-4d34-9f80-436b9bddb930, Quiroga, J. (Jorge)|||/items/580a0a4e-16a6-446c-840c-3e225592fa4b, Conchillo, F. (F.)|||/items/2a1de8bb-19db-4237-9a64-663ae7d0ac1f, Prieto, J. (Jesús)|||/items/0d9c3dec-4a09-400d-8c83-23ece1096c71, Macias, E. (Elena)|||/items/9863e1dd-16aa-4e7b-81aa-5c84fedca0d8
Tipo de recurso: artículo
Fecha de publicación:1991
País:España
Institución:Universidad de Navarra
Repositorio:Dadun. Depósito Académico Digital de la Universidad de Navarra
Idioma:español
OAI Identifier:oai:dadun.unav.edu:10171/29581
Acceso en línea:https://hdl.handle.net/10171/29581
Access Level:acceso abierto
Palabra clave:Ursodeoxycholic acid
Primary biliary
Cirrhosis
Pruritus
Bilirubin
Hepatología
id ES_8ddf520fc0b92aefe2c2ee9c468d7421
oai_identifier_str oai:dadun.unav.edu:10171/29581
network_acronym_str ES
network_name_str España
repository_id_str
spelling Tratamiento de la cirrosis biliar primaria con ácido ursodesoxicólico. Resultados a corto y medio plazo y relación con el estudio de la enfermedadGarcia-Villarreal, L. (Luis)|||/items/397c8983-3fdb-45d3-9d5b-20b34f79cc6aZozaya, J.M. (José Manuel)|||/items/70a8a1ed-51c0-4166-9547-ecde1a29e8a1Garcia, N. (Nicolás)|||/items/f28987d6-9dc4-4d34-9f80-436b9bddb930Quiroga, J. (Jorge)|||/items/580a0a4e-16a6-446c-840c-3e225592fa4bConchillo, F. (F.)|||/items/2a1de8bb-19db-4237-9a64-663ae7d0ac1fPrieto, J. (Jesús)|||/items/0d9c3dec-4a09-400d-8c83-23ece1096c71Macias, E. (Elena)|||/items/9863e1dd-16aa-4e7b-81aa-5c84fedca0d8Ursodeoxycholic acidPrimary biliaryCirrhosisPruritusBilirubinHepatologíaWe present the results of the treatment with ursodeoxycholic acid (UDCA, 7-9 mg/kg body weight daily) of 17 patients with primary biliary cirrhosis (8 in stages I-II; 9 in stages III-IV). At two months the mean values of alkaline phosphatase, gammaglutamiltranspeptidase, alanine and aspartate aminotransferase were reduced (p less than 0.001, p less than 0.001, p less than 0.01 and p less than 0.01 respectively). This improvement persisted without increase during the first year. At two months the total bilirubin value was reduced (p less than 0.01) associated with a reduction in the conjugated fraction (p less than 0.05). Cholesterol and gammaglobulin mean values also decreased at two months (p less than 0.05). We found no changes in IgM levels and antimitochondrial antibody titers. The improvement was similar in both groups (early I-II and advanced III-IV stages) and the treatment showed no undesirable effects either in early or advanced stages. Almost all the patients with pruritus (6 out of 7) improved with the treatment and the use of cholestyramine was reduced in allThe Spanish Society of Digestive PathologyDadun. Depósito Académico Digital Universidad de Navarra20132013-08-1719911991-01-0119911991-01-01journal articlehttp://purl.org/coar/resource_type/c_6501info:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/10171/29581reponame:Dadun. Depósito Académico Digital de la Universidad de Navarrainstname:Universidad de NavarraEspañolspaopen accesshttp://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessoai:dadun.unav.edu:10171/295812026-06-21T12:47:57Z
dc.title.none.fl_str_mv Tratamiento de la cirrosis biliar primaria con ácido ursodesoxicólico. Resultados a corto y medio plazo y relación con el estudio de la enfermedad
title Tratamiento de la cirrosis biliar primaria con ácido ursodesoxicólico. Resultados a corto y medio plazo y relación con el estudio de la enfermedad
spellingShingle Tratamiento de la cirrosis biliar primaria con ácido ursodesoxicólico. Resultados a corto y medio plazo y relación con el estudio de la enfermedad
Garcia-Villarreal, L. (Luis)|||/items/397c8983-3fdb-45d3-9d5b-20b34f79cc6a
Ursodeoxycholic acid
Primary biliary
Cirrhosis
Pruritus
Bilirubin
Hepatología
title_short Tratamiento de la cirrosis biliar primaria con ácido ursodesoxicólico. Resultados a corto y medio plazo y relación con el estudio de la enfermedad
title_full Tratamiento de la cirrosis biliar primaria con ácido ursodesoxicólico. Resultados a corto y medio plazo y relación con el estudio de la enfermedad
title_fullStr Tratamiento de la cirrosis biliar primaria con ácido ursodesoxicólico. Resultados a corto y medio plazo y relación con el estudio de la enfermedad
title_full_unstemmed Tratamiento de la cirrosis biliar primaria con ácido ursodesoxicólico. Resultados a corto y medio plazo y relación con el estudio de la enfermedad
title_sort Tratamiento de la cirrosis biliar primaria con ácido ursodesoxicólico. Resultados a corto y medio plazo y relación con el estudio de la enfermedad
dc.creator.none.fl_str_mv Garcia-Villarreal, L. (Luis)|||/items/397c8983-3fdb-45d3-9d5b-20b34f79cc6a
Zozaya, J.M. (José Manuel)|||/items/70a8a1ed-51c0-4166-9547-ecde1a29e8a1
Garcia, N. (Nicolás)|||/items/f28987d6-9dc4-4d34-9f80-436b9bddb930
Quiroga, J. (Jorge)|||/items/580a0a4e-16a6-446c-840c-3e225592fa4b
Conchillo, F. (F.)|||/items/2a1de8bb-19db-4237-9a64-663ae7d0ac1f
Prieto, J. (Jesús)|||/items/0d9c3dec-4a09-400d-8c83-23ece1096c71
Macias, E. (Elena)|||/items/9863e1dd-16aa-4e7b-81aa-5c84fedca0d8
author Garcia-Villarreal, L. (Luis)|||/items/397c8983-3fdb-45d3-9d5b-20b34f79cc6a
author_facet Garcia-Villarreal, L. (Luis)|||/items/397c8983-3fdb-45d3-9d5b-20b34f79cc6a
Zozaya, J.M. (José Manuel)|||/items/70a8a1ed-51c0-4166-9547-ecde1a29e8a1
Garcia, N. (Nicolás)|||/items/f28987d6-9dc4-4d34-9f80-436b9bddb930
Quiroga, J. (Jorge)|||/items/580a0a4e-16a6-446c-840c-3e225592fa4b
Conchillo, F. (F.)|||/items/2a1de8bb-19db-4237-9a64-663ae7d0ac1f
Prieto, J. (Jesús)|||/items/0d9c3dec-4a09-400d-8c83-23ece1096c71
Macias, E. (Elena)|||/items/9863e1dd-16aa-4e7b-81aa-5c84fedca0d8
author_role author
author2 Zozaya, J.M. (José Manuel)|||/items/70a8a1ed-51c0-4166-9547-ecde1a29e8a1
Garcia, N. (Nicolás)|||/items/f28987d6-9dc4-4d34-9f80-436b9bddb930
Quiroga, J. (Jorge)|||/items/580a0a4e-16a6-446c-840c-3e225592fa4b
Conchillo, F. (F.)|||/items/2a1de8bb-19db-4237-9a64-663ae7d0ac1f
Prieto, J. (Jesús)|||/items/0d9c3dec-4a09-400d-8c83-23ece1096c71
Macias, E. (Elena)|||/items/9863e1dd-16aa-4e7b-81aa-5c84fedca0d8
author2_role author
author
author
author
author
author
dc.contributor.none.fl_str_mv Dadun. Depósito Académico Digital Universidad de Navarra
dc.subject.none.fl_str_mv Ursodeoxycholic acid
Primary biliary
Cirrhosis
Pruritus
Bilirubin
Hepatología
topic Ursodeoxycholic acid
Primary biliary
Cirrhosis
Pruritus
Bilirubin
Hepatología
description We present the results of the treatment with ursodeoxycholic acid (UDCA, 7-9 mg/kg body weight daily) of 17 patients with primary biliary cirrhosis (8 in stages I-II; 9 in stages III-IV). At two months the mean values of alkaline phosphatase, gammaglutamiltranspeptidase, alanine and aspartate aminotransferase were reduced (p less than 0.001, p less than 0.001, p less than 0.01 and p less than 0.01 respectively). This improvement persisted without increase during the first year. At two months the total bilirubin value was reduced (p less than 0.01) associated with a reduction in the conjugated fraction (p less than 0.05). Cholesterol and gammaglobulin mean values also decreased at two months (p less than 0.05). We found no changes in IgM levels and antimitochondrial antibody titers. The improvement was similar in both groups (early I-II and advanced III-IV stages) and the treatment showed no undesirable effects either in early or advanced stages. Almost all the patients with pruritus (6 out of 7) improved with the treatment and the use of cholestyramine was reduced in all
publishDate 1991
dc.date.none.fl_str_mv 1991
1991-01-01
1991
1991-01-01
2013
2013-08-17
dc.type.none.fl_str_mv journal article
http://purl.org/coar/resource_type/c_6501
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv https://hdl.handle.net/10171/29581
url https://hdl.handle.net/10171/29581
dc.language.none.fl_str_mv Español
spa
language_invalid_str_mv Español
language spa
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv The Spanish Society of Digestive Pathology
publisher.none.fl_str_mv The Spanish Society of Digestive Pathology
dc.source.none.fl_str_mv reponame:Dadun. Depósito Académico Digital de la Universidad de Navarra
instname:Universidad de Navarra
instname_str Universidad de Navarra
reponame_str Dadun. Depósito Académico Digital de la Universidad de Navarra
collection Dadun. Depósito Académico Digital de la Universidad de Navarra
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869413082045874176
score 15,301603